MJ2204 14th Annual John D. Loeser Pain Conference: Chronic Pain Management for Primary Care in a Changing World

Thursday, November 4, 2021, 7:55 AM - 5:05 PM, Online

AMA PRA Category 1 Credits™ (7.50 hours), Non-Physician (7.50 hours)

Chronic pain is a common, complex, and challenging condition, where understanding the biological, social, physical and psychological contexts is vital to successful outcomes in primary care. Chronic musculoskeletal pain is one of the most intractable clinical problems faced by clinicians and patients and is both amplified and perpetuated by psychological and socially traumatic events. Among current health and social traumas, the current COVID-19 pandemic has exacerbated long-standing difficulties accessing already scarce multidisciplinary pain care, threatening vulnerable communities and socially isolating and economically disrupting the lives of our patients with chronic pain.

The 14th Annual John D. Loeser Pain Conference will focus on the practical approaches to management of common painful musculoskeletal conditions, the impact of chronic illness and a pandemic on chronic pain management and how to support patients chronic pain care regimens utilizing virtual technologies, updates on opioid prescribing rules, guidelines and best practices including new rules for prescribing opioids for older adults, and what how to manage buprenorphine for chronic pain and understanding the role cannabinoids may play in pain treatment.

Online via Live Webinar
November 4, 2021

Course registration has closed effective Wednesday, November 3, at 12:00 pm Pacific Time.

1. Differentiate peripheral and centrally generated pains.
2. Select focus on diagnosis and treatment of common musculoskeletal conditions in a primary care setting.
3. Recognize features of physical therapy/exercise programs best able to work with patients with pain conditions.
4. Explain to a patient the three basic patterns of joint pain and the purpose of diagnostic testing.
5. Outline novel COVID-19 pain syndromes and maintenance of existing chronic pain treatment regimens in an era of stress.
6. Discuss use of telemedicine technologies for pain for patient education, exercise and mindfulness training.
7. Outline a process to address difficult patient interactions with mindfulness, empathy and compassion.
8. Describe clinical implications of 2021 BREE opioid prescribing guidelines for older adults.
9. Develop a detailed plan including ways to trouble shoot the transition from full agonist opioid to buprenorphine.
10. Determine whether or not a patient on long-term opioid treatment should be weaned from opioids and how to formulate the necessary documentation.
11. Formulate answers to common patient questions about cannabinoids including how to counsel patients to seek informed advice when shopping for over-the-counter products.

All Learners	$200.00
*Resident/Fellow	$125.00

*Resident/Fellow rate requires written confirmation of current status. Failure to provide required documentation may result in an additional balance owed. 

Registration rates increase by $25 starting October 4, 2021.

Course registration has closed effective Wednesday, November 3, at 12:00 pm Pacific Time.

Continuing Medical Education at the University of Washington is a self-sustaining unit and does not depend on or receive public monies in support of its educational efforts. The course fees are estimated to cover transcript of AMA PRA Category 1 Credits™, access to online instruction materials, course logistics, faculty planning and salaries.

If you have not received confirmation prior to the course start, please contact the CME office at [email protected]. Continuing Medical Education will not be responsible for expenses incurred by an individual who is not confirmed.

CANCELLATION AND REFUND POLICY
The Office of Continuing Medical Education must receive written notification of your cancellation by October 21, 2021. A $75.00 processing fee will be deducted from refund requests received by this date. No refunds will be issued following October 21, 2021. 

The Office of Continuing Medical Education reserves the right to cancel this course twenty (20) days prior to the course date when a minimum enrollment is not met or for other reasons that prevent the University from holding the course. Each registrant will be notified by written notification and a full refund. The University of Washington is not responsible for any other costs incurred. Contact the CME Office with questions via email: [email protected].

WHO SHOULD ATTEND
Primary care providers (PCPs), including MDs, DOs, ARNPs, NPs, and PAs working in clinic settings where they work with acute or chronic non-cancer pain. Other interested parties may include providers in rehabilitation medicine, occupational medicine, psychiatry, psychology, nursing, physical therapy, social work, pharmacy and trainees in all the above fields.

ONLINE CONFERENCE SYLLABUS
Instruction materials will be available online at uwcme.org (for conference registrants only) beginning November 1, 2021. Content will be recorded and available to attendees for educational purposes. Attendees will be notified when recordings are available, approximately 4-6 weeks after course completion. CME credit is available only for attending the live webinar; no credit is available for watching the recorded lectures. Webinar registrants will receive instructions by email prior to the course.

SYSTEM REQUIREMENTS
Prior to the start, please ensure you have the appropriate system requirements to participate in the webinar. More information about the recommended technical requirements is below. No refunds will be available for technical issues not controlled by UW CME. Reliable internet access is necessary. It is strongly recommended that you test your Zoom connection prior to this activity.

Minimum browser requirements for successful access and completion of this activity are as follows:

• Chrome version 70.0 or newer, or Firefox version 63.0 or newer.
• Internet Explorer and Safari are not recommended with the UW CME website.
• You may use any browser to view the Zoom webinar.

COPYRIGHT
The content is the property of the University of Washington and is protected by law, including but not limited to copyright and trademark statutes. This content is for educational purposes only and may not be used for commercial gain. The University of Washington reserves the right to revise or withdraw content from use. Redistribution of this content is strictly prohibited.

SPECIAL SERVICES
The University of Washington reaffirms its policy of equal opportunity regardless of race, color, creed, religion, national origin, sex, sexual orientation, age, marital status, disability, or status as a disabled veteran or Vietnam era veteran in accordance with University policy and applicable federal and state statutes and regulations. The University of Washington is committed to providing access and reasonable accommodation in its services, programs, activities, education and employment for individuals with disabilities. To request disability accommodation, contact the Disability Services Office at least ten (10) days prior to the start of the conference at 206-543-6450 (voice), 206-543-6452 (TTY), 206-685-7264 (fax), or [email protected].  

Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The University of Washington School of Medicine designates this Live Activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Thursday, November 4, 2021